Join
Live feed
·
PRReleasevia Quantisnow
Geron Corporation logo
Royalty Pharma plc logo

Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GERN (Geron Corporation), RPRX (Royalty Pharma plc) and more on Quantisnow.